Developer docs
API playgroundTry for free, no card

Search company profiles

BioInteractions

Full company profile

uuid0007mhj

Namestring
BioInteractions
Legal namestring
BioInteractions Ltd
Company typeenum
Private
Founded yearint
1992
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersReading, United Kingdom
HQ citystring
Reading
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biocompatible medical coatings, antithrombogenic surface treatments, antimicrobial device coatings, hydrophilic medical coatings, medical device surface engineering
Industry2 codes
PRIMARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment
SECONDARYIMAEAGAB
Industrial & Protective Coatings
NAICS code2 codes
  • Paint and Coating Manufacturing32551
  • Paint and Coating Manufacturing325510
SIC code2 codes
  • Paints, Varnishes, Lacquers, Enamels & Allied Prods2851
  • Miscellaneous Chemical Products2890
Product category
Medical Device Coatings
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Licensing Contracts
TypeLicensing Royalties
Description

BioInteractions has secured licensing contracts with major medical device manufacturers worldwide for the use of their coating technologies on approved devices.

biointeractions.com
2Product Pathway Partnership Service
TypeProfessional Services
Description

Integrated end-to-end coating service supporting partners from concept to commercialisation, including application development, tooling, testing, regulatory submission, and scaled assembly.

biointeractions.com
3Bespoke Materials
TypeOne Time License
Description

Custom-made coating solutions for partners requiring surface treatments outside standard offerings, leveraging 30+ years of biocompatible material expertise.

biointeractions.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1AstutePlus®
Description

Advanced antithrombogenic Surface-Active Therapeutic coating designed for long-term blood-contacting medical devices, providing zero-leaching, permanently effective thrombosis prevention

biointeractions.com
+5 more records
Core offering1 text field

BioInteractions develops and supplies proprietary zero-leaching biocompatible coatings for medical devices under its Surface-Active Systems platform. Its core commercial products are AstutePlus (antithrombogenic coating for blood-contacting devices), TridAnt (permanent antimicrobial coating), and Assist (durable hydrophilic friction-reduction coating), complemented by bespoke custom coating development and an end-to-end Product Pathway Partnership service for OEMs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Prevents 99% of thrombosis formation
+3 more records
Product overview1 text field

BioInteractions offers a portfolio of biocompatible coating solutions organized under the Surface-Active Systems platform. The core product line includes three main coatings: AstutePlus® (advanced antithrombogenic for blood-contacting devices), TridAnt® (enhanced antimicrobial for infection prevention), and Assist™ (durable hydrophilic for friction reduction). These are complemented by Surface-Active Systems, a new category combining Surface-Active Therapeutics and Surface-Active Materials. The company also provides Bespoke Materials services for custom coating solutions and a Product Pathway Partnership service for end-to-end development support.

Product and service5 records
1AstutePlus Advanced Antithrombogenic Coating
CategoryBiocompatible Surface Coating
Description

Zero-leaching, permanently effective antithrombogenic Surface-Active Therapeutic coating for long-term blood-contacting medical devices. Multi-faceted action blocks the blood cascade, deactivates platelets, and prevents blood components from sticking. Prevents 99% of thrombosis and fibrin sheath formation, and mimics endothelial tissue. Targeted at medical device OEMs producing stents, valves, catheters, vascular grafts, and oxygenators.

2TridAnt Enhanced Antimicrobial Coating
CategoryBiocompatible Surface Coating
Description

Zero-leaching permanent antimicrobial Surface-Active Therapeutic coating effective against gram-negative (E. coli), gram-positive bacteria (including MRSA), yeast, and fungi. Uses a Contact Kill Mechanism to inhibit protein deposition and bacterial adhesion while killing pathogens. Designed for medical device OEMs requiring infection-prevention coatings on implantable and indwelling devices.

3Assist Durable Hydrophilic Coating
CategoryBiocompatible Surface Coating
Description

Durable hydrophilic Surface-Active Material engineered to reduce friction on medical device surfaces, suitable for high-stress applications including balloon catheters and joint devices. Features industry-leading coefficient of friction (<0.003), instant activation, minimal swelling (2%), and ultra-low particulation. UV or heat cured. Targeted at medical device OEMs needing lubricious, durable surface treatments.

4Bespoke Materials
CategoryCustom Coating Development
Description

Custom-made coating solutions for OEM partners requiring surface treatments outside standard clinical areas. Leverages 30+ years of biocompatible material expertise, including biocompatible polymers, biodegradable materials, drug delivery systems, and biomedical technologies, developed on-site at the company's production laboratory in Shinfield, UK.

5Product Pathway Partnership
CategoryCoating Support Service
Description

Integrated end-to-end coating service supporting OEM partners from concept to commercialisation. Includes application development, tooling, testing, regulatory submission, and scaled assembly services, with regulatory compliance at its core. Designed for medical device manufacturers seeking a single partner across the device coating lifecycle.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

BioInteractions works with major manufacturers worldwide in the areas of cardiothoracic surgery, drug delivery, catheters, and long-term implantable medical devices such as vascular grafts. The company has secured licensing contracts with these manufacturers for their coating technologies.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Innovative Surface Technologies (ISurTec) develops specialized surface coatings including hydrophilic, antimicrobial, and drug-eluting coatings for medical devices. Direct peer in the niche biocompatible coating space serving similar OEM applications.

TypeEmerging player
Description

AST Products develops surface modification technologies including lubricious and antimicrobial coatings for medical and industrial applications. Comparable niche competitor in functional surface treatments, though smaller scale and broader end-market exposure.

TypeBroad incumbent
Description

Teleflex is a major medical device OEM whose coated catheter and vascular access products (e.g., Certofix) are named customers/partners of BioInteractions. As a downstream OEM rather than a coating technology peer, it is a meaningful adjacent player whose commercial decisions directly affect BioInteractions' licensing revenue.

TypeDirect peer
Description

Covalon Technologies develops antimicrobial and biocompatible coatings for medical devices, with overlap in infection-prevention coatings similar to BioInteractions' TridAnt. Both target the healthcare-associated infection reduction use case for medical device OEMs.

TypeBroad incumbent
Description

DSM Biomedical (formerly DSM Dyneema and Polymer Technology Group) is a larger incumbent supplying biocompatible materials and coatings for medical devices, including drug-delivery and regenerative coatings. Overlaps directly with BioInteractions in antithrombogenic and biocompatible surface technologies but operates at substantially larger scale and broader product portfolio.

6Biocoat
TypeDirect peer
Description

Biocoat specializes in hydrophilic coatings for medical devices, directly comparable to BioInteractions' Assist product. Serves similar OEM customers in catheters and minimally invasive devices with focused surface coating technology.

TypeDirect peer
Description

Surmodics is a direct competitor providing specialized surface coatings for medical devices, including hydrophilic, antithrombogenic, and drug-delivery coatings. It serves the same medical device OEM customer base across interventional and implantable devices, making it the most comparable public peer in biocompatible medical device coatings.

TypeEmerging player
Description

N8 Medical develops antimicrobial coating technologies for medical devices, focused on infection prevention. Comparable to BioInteractions' TridAnt in addressing HCAI risk through surface-bound antimicrobial approaches, though at earlier commercial scale.

TypeDirect peer
Description

Harland Medical Systems provides medical device surface coatings and surface treatment technologies, including lubricious and antimicrobial coatings. Directly comparable niche competitor serving medical device OEMs with similar coating services.

10AdvaTec
TypeEmerging player
Description

AdvaTec develops antimicrobial and anti-thrombogenic coatings for medical devices, with overlap in biocompatible infection-prevention surfaces. Smaller competitor focused on similar cardiovascular and catheter device applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioInteractions

Medical Device Coatingsbiointeractions.com

BioInteractions firmographics

Firmographics
Name
BioInteractions
Legal name
BioInteractions Ltd
Website
https://biointeractions.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

BioInteractions industry classification

Industry
Product category
Medical Device Coatings
NAICS
Paint and Coating Manufacturing (32551), Paint and Coating Manufacturing (325510)
SIC
Paints, Varnishes, Lacquers, Enamels & Allied Prods (2851), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment
SECONDARYIMAEAGAB
Industrial & Protective Coatings

Keywords

  • Biocompatible medical coatings
  • Antithrombogenic surface treatments
  • Antimicrobial device coatings
  • Hydrophilic medical coatings
  • Medical device surface engineering

Where BioInteractions is headquartered

Location

Headquarters

HQ city
Reading
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

BioInteractions business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Licensing Contracts: BioInteractions has secured licensing contracts with major medical device manufacturers worldwide for the use of their coating technologies on approved devices.
  2. Product Pathway Partnership Service: Integrated end-to-end coating service supporting partners from concept to commercialisation, including application development, tooling, testing, regulatory submission, and scaled assembly.
  3. Bespoke Materials: Custom-made coating solutions for partners requiring surface treatments outside standard offerings, leveraging 30+ years of biocompatible material expertise.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

BioInteractions product offering

Product offering

Core offering

BioInteractions develops and supplies proprietary zero-leaching biocompatible coatings for medical devices under its Surface-Active Systems platform. Its core commercial products are AstutePlus (antithrombogenic coating for blood-contacting devices), TridAnt (permanent antimicrobial coating), and Assist (durable hydrophilic friction-reduction coating), complemented by bespoke custom coating development and an end-to-end Product Pathway Partnership service for OEMs.

Product overview

BioInteractions offers a portfolio of biocompatible coating solutions organized under the Surface-Active Systems platform. The core product line includes three main coatings: AstutePlus® (advanced antithrombogenic for blood-contacting devices), TridAnt® (enhanced antimicrobial for infection prevention), and Assist™ (durable hydrophilic for friction reduction). These are complemented by Surface-Active Systems, a new category combining Surface-Active Therapeutics and Surface-Active Materials. The company also provides Bespoke Materials services for custom coating solutions and a Product Pathway Partnership service for end-to-end development support.

Differentiator

Problem solved

Functional benefit

Brands

  • AstutePlus®: Advanced antithrombogenic Surface-Active Therapeutic coating designed for long-term blood-contacting medical devices, providing zero-leaching, permanently effective thrombosis prevention
  • TridAnt®
  • Assist™
  • Surface-Active Systems
  • Surface-Active Therapeutics
  • Surface-Active Materials

Products and services

  • AstutePlus Advanced Antithrombogenic Coating Zero-leaching, permanently effective antithrombogenic Surface-Active Therapeutic coating for long-term blood-contacting medical devices. Multi-faceted action blocks the blood cascade, deactivates platelets, and prevents blood components from sticking. Prevents 99% of thrombosis and fibrin sheath formation, and mimics endothelial tissue. Targeted at medical device OEMs producing stents, valves, catheters, vascular grafts, and oxygenators.
  • TridAnt Enhanced Antimicrobial Coating Zero-leaching permanent antimicrobial Surface-Active Therapeutic coating effective against gram-negative (E. coli), gram-positive bacteria (including MRSA), yeast, and fungi. Uses a Contact Kill Mechanism to inhibit protein deposition and bacterial adhesion while killing pathogens. Designed for medical device OEMs requiring infection-prevention coatings on implantable and indwelling devices.
  • Assist Durable Hydrophilic Coating Durable hydrophilic Surface-Active Material engineered to reduce friction on medical device surfaces, suitable for high-stress applications including balloon catheters and joint devices. Features industry-leading coefficient of friction (<0.003), instant activation, minimal swelling (2%), and ultra-low particulation. UV or heat cured. Targeted at medical device OEMs needing lubricious, durable surface treatments.
  • Bespoke Materials Custom-made coating solutions for OEM partners requiring surface treatments outside standard clinical areas. Leverages 30+ years of biocompatible material expertise, including biocompatible polymers, biodegradable materials, drug delivery systems, and biomedical technologies, developed on-site at the company's production laboratory in Shinfield, UK.
  • Product Pathway Partnership Integrated end-to-end coating service supporting OEM partners from concept to commercialisation. Includes application development, tooling, testing, regulatory submission, and scaled assembly services, with regulatory compliance at its core. Designed for medical device manufacturers seeking a single partner across the device coating lifecycle.

Quantifiable outcome

  • Prevents 99% of thrombosis formation
  • +3 more outcomes

Companies that use BioInteractions

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles2 records

BioInteractions technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

BioInteractions partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Major Medical Device Manufacturers WorldwidecoreOEM/ Whitelabel/ Licensing PartnerBioInteractions works with major manufacturers worldwide in the areas of cardiothoracic surgery, drug delivery, catheters, and long-term implantable medical devices such as vascular grafts. The company has secured licensing contracts with these manufacturers for their coating technologies.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

BioInteractions competitors and assessment

Company assessment

Direct peers

  • Innovative Surface Technologies: Innovative Surface Technologies (ISurTec) develops specialized surface coatings including hydrophilic, antimicrobial, and drug-eluting coatings for medical devices. Direct peer in the niche biocompatible coating space serving similar OEM applications.
  • Covalon Technologies: Covalon Technologies develops antimicrobial and biocompatible coatings for medical devices, with overlap in infection-prevention coatings similar to BioInteractions' TridAnt. Both target the healthcare-associated infection reduction use case for medical device OEMs.
  • Biocoat: Biocoat specializes in hydrophilic coatings for medical devices, directly comparable to BioInteractions' Assist product. Serves similar OEM customers in catheters and minimally invasive devices with focused surface coating technology.
  • Surmodics: Surmodics is a direct competitor providing specialized surface coatings for medical devices, including hydrophilic, antithrombogenic, and drug-delivery coatings. It serves the same medical device OEM customer base across interventional and implantable devices, making it the most comparable public peer in biocompatible medical device coatings.
  • Harland Medical Systems: Harland Medical Systems provides medical device surface coatings and surface treatment technologies, including lubricious and antimicrobial coatings. Directly comparable niche competitor serving medical device OEMs with similar coating services.

Emerging players

  • AST Products: AST Products develops surface modification technologies including lubricious and antimicrobial coatings for medical and industrial applications. Comparable niche competitor in functional surface treatments, though smaller scale and broader end-market exposure.
  • N8 Medical: N8 Medical develops antimicrobial coating technologies for medical devices, focused on infection prevention. Comparable to BioInteractions' TridAnt in addressing HCAI risk through surface-bound antimicrobial approaches, though at earlier commercial scale.
  • AdvaTec: AdvaTec develops antimicrobial and anti-thrombogenic coatings for medical devices, with overlap in biocompatible infection-prevention surfaces. Smaller competitor focused on similar cardiovascular and catheter device applications.

Broad incumbents

  • Teleflex: Teleflex is a major medical device OEM whose coated catheter and vascular access products (e.g., Certofix) are named customers/partners of BioInteractions. As a downstream OEM rather than a coating technology peer, it is a meaningful adjacent player whose commercial decisions directly affect BioInteractions' licensing revenue.
  • DSM Biomedical: DSM Biomedical (formerly DSM Dyneema and Polymer Technology Group) is a larger incumbent supplying biocompatible materials and coatings for medical devices, including drug-delivery and regenerative coatings. Overlaps directly with BioInteractions in antithrombogenic and biocompatible surface technologies but operates at substantially larger scale and broader product portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

BioInteractions social profiles

Digital presence

BioInteractions compliance and trust

Trust signal

Compliance3 records

BioInteractions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioInteractions leadership team

Management profile

Number of profiles

Profiles2 records

BioInteractions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioInteractions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioInteractions

What does BioInteractions do?

BioInteractions develops and supplies proprietary zero-leaching biocompatible coatings for medical devices under its Surface-Active Systems platform. Its core commercial products are AstutePlus (antithrombogenic coating for blood-contacting devices), TridAnt (permanent antimicrobial coating), and Assist (durable hydrophilic friction-reduction coating), complemented by bespoke custom coating development and an end-to-end Product Pathway Partnership service for OEMs.

Is BioInteractions a public or private company?

BioInteractions is a private company. It is classified as family owned and is currently operating.

When was BioInteractions founded?

BioInteractions was founded in 1992. It employs 11 to 50 people.

Where is BioInteractions based?

BioInteractions is headquartered in Reading, United Kingdom, in the Europe region.

How does BioInteractions make money?

Three revenue lines are on record. Licensing Contracts are the primary driver. The others are product Pathway Partnership Service and bespoke Materials.

Who are BioInteractions's main competitors?

Direct peers on record are Innovative Surface Technologies, Covalon Technologies, Biocoat, Surmodics and Harland Medical Systems. Emerging players are AST Products, N8 Medical and AdvaTec. Broad incumbents are Teleflex and DSM Biomedical.

Does BioInteractions have an API?

No public API is recorded for BioInteractions.

What industry is BioInteractions in?

BioInteractions's product category is Medical Device Coatings. Its primary akta.pro industry code is IMAIAKAM, Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating), with a secondary code of IMAEAGAB, Industrial & Protective Coatings. Its NAICS code is 32551 and its SIC code is 2851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VascularnewsLeading vascular access surgeons call for solutions to fibrin sheath formation on central venous catheters at CX 2026At the CX 2026 symposium in London, vascular access surgeons highlighted thrombosis and fibrin sheath formation as primary complications limiting central venous catheter lifespan, calling for increased research and innovation. Presentations indicated that haemocompatible-coated catheters from Medtronic and antithrombogenic coatings from BioInteractions showed promise in reducing these issues compared to uncoated devices. The event underscored a significant evidence gap in clinical decision-making for dialysis access, with only 16% of clinicians citing published literature as a primary factor in device selection.GlobeNewswireMedical Device Coating & Surface Modification Market Forecast Report 2025-2035, with Profiles of Biocoat, BioInteractions, Biomerics, Formacoat, LVD Biotech, Polyzen, Surmodics, TUA Systems, and MoreResearchAndMarkets published a market forecast report estimating the global medical device coatings market will grow from USD 8.8 billion to USD 17.3 billion by 2040, representing a compound annual growth rate of 7.1% during the forecast period. The report profiles over 80 players offering medical device coating services globally, with North America capturing the largest market share (49%) while Asia-Pacific is expected to grow at the fastest rate (8.4% CAGR). Key growth drivers include the rising elderly population, increasing chronic illnesses, demand for minimally invasive procedures, and heightened focus on reducing hospital-acquired infections through antimicrobial coatings.Med-Tech InsightsBioInteractions launches Surface-Active Systems – a “paradigm shift” for medical device coatingBioInteractions launched Surface-Active Systems, a new category of non-leaching medical device coatings. The category includes Surface-Active Therapeutics and Surface-Active Materials, designed to prevent infection and thrombosis without systemic drug exposure. The company aims to improve implant performance and reduce hospital readmissions.openPR.comAntimicrobial Coatings for Medical Devices Market to Witness Remarkable Growth with AST Products Inc., BASF SE, Biointeractions LtdThe antimicrobial coatings for medical devices market is projected to grow from USD 2.27 billion in 2025 to USD 5.88 billion by 2032, a CAGR of 14.2%. Key players include AST Products Inc., BASF SE, and Biointeractions Ltd, with segmentation by device type, coating type, and end-user.Med-Tech InsightsEvolving surfaces for lifetime implantsBioInteractions' Surface Active Therapeutics use polymer matrices to provide antimicrobial and antithrombogenic protection for medical implants. Coatings like TridAnt and Astute target pathogens and prevent clotting, with applications on catheters, heart valves, and stents. The technology aims to ensure lifetime efficacy and reduce infections and complications.